InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by GOODMAN JONATHAN R., Director. Insider active across 1 company, notably POINT Biopharma Global Inc.. In total, 6 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €37k. History available since 18 November 2022. The latest transaction was filed on 18 November 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
6 of 6 declarations
Jonathan R. Goodman is a Board Member at Point Biopharma Global Inc. He is responsible for overseeing the company's strategies and regulatory compliance. His experience in the biopharmaceutical sector is a valuable asset to the board.